Liangliang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liangliang Zhang has a total of 199 co-authors. Here are the top co-authors by number of shared publications:
- Shulin Zhao
Guangxi Normal University
64 shared publications Yong Huang
State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, P. R. China
15 shared publicationsJingjin Zhao
Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), University Engineering Research Center for Chemistry of Characteristic Medicinal Resources (Guangxi) Guangxi Normal University Guilin China
13 shared publications- Shengqiang Hu
Guangxi Normal University
12 shared publications - Hong Liang
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, University Engineering Research Center for Chemistry of Characteristic Medicinal Resources (Guangxi), School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China
10 shared publications Mengjiao Huang
Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry and Pharmaceutical Sciences
9 shared publications
Latest Publications
- 13 November 2026
- Published by Wiley in Advanced Healthcare Materials
Switching Catalytic Modes: A pH‐Responsive Bimetallic Nanozyme for Dynamic Microenvironment Remodeling and Infected Wound Self‐Adaptive Treatment
Bacterial‐infected wound healing is severely impeded by the complex, self‐perpetuating wound microenvironment (WME) characterized by biofilm infection, hypoxia, excessive oxidative stress, and persistent inflammation. Effective repair demands smart therapeutic interventions capable of autonomously adapting to the evolving pathological landscape—a feature absent in most current treatments. To address this critical need, a novel bimetallic nanozyme (MCCN) is engineered by integrating manganese (III) porphyrin into cobalt‐doped mesoporous carbon‐nitrogen nanocubes, serving as a smart modulator for autonomous WME remodeling. The MCCN exhibits oxidase (OXD), superoxide dismutase (SOD), and catalase (CAT)‐like activities, and enables pH‐responsive catalytic switching. In acidic biofilms, it initiates a self‐sustaining OXD/SOD/CAT catalytic cycle that continuously generates singlet oxygen for biofilm eradication. As infection resolves and pH neutralizes, it autonomously switches to a SOD/CAT cascade that scavenges reactive oxygen species and supplies oxygen, alleviating oxidative stress and hypoxia while promoting tissue regeneration. The data demonstrate that the MCCN integrates potent antibacterial, antioxidant, anti‐inflammatory, and pro‐angiogenic functions, making it an efficient and safe nanomedicine for treating infected wounds via a WME self‐adaptive intervention pathway. Our work establishes a groundbreaking “smart catalytic” paradigm for dynamic pathological microenvironment remodeling, offering a promising therapeutic avenue for refractory wounds and other microenvironment‐associated diseases.
- 13 November 2026
- Published by Wiley in Advanced Healthcare Materials
Switching Catalytic Modes: A pH‐Responsive Bimetallic Nanozyme for Dynamic Microenvironment Remodeling and Infected Wound Self‐Adaptive Treatment
Bacterial‐infected wound healing is severely impeded by the complex, self‐perpetuating wound microenvironment (WME) characterized by biofilm infection, hypoxia, excessive oxidative stress, and persistent inflammation. Effective repair demands smart therapeutic interventions capable of autonomously adapting to the evolving pathological landscape—a feature absent in most current treatments. To address this critical need, a novel bimetallic nanozyme (MCCN) is engineered by integrating manganese (III) porphyrin into cobalt‐doped mesoporous carbon‐nitrogen nanocubes, serving as a smart modulator for autonomous WME remodeling. The MCCN exhibits oxidase (OXD), superoxide dismutase (SOD), and catalase (CAT)‐like activities, and enables pH‐responsive catalytic switching. In acidic biofilms, it initiates a self‐sustaining OXD/SOD/CAT catalytic cycle that continuously generates singlet oxygen for biofilm eradication. As infection resolves and pH neutralizes, it autonomously switches to a SOD/CAT cascade that scavenges reactive oxygen species and supplies oxygen, alleviating oxidative stress and hypoxia while promoting tissue regeneration. The data demonstrate that the MCCN integrates potent antibacterial, antioxidant, anti‐inflammatory, and pro‐angiogenic functions, making it an efficient and safe nanomedicine for treating infected wounds via a WME self‐adaptive intervention pathway. Our work establishes a groundbreaking “smart catalytic” paradigm for dynamic pathological microenvironment remodeling, offering a promising therapeutic avenue for refractory wounds and other microenvironment‐associated diseases.
- 3 November 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
A Data-Driven Framework for UPLC Method Recommendation in High-Throughput Reaction Analysis
High-throughput experimentation (HTE) requires rapid and reliable chromatographic analysis of complex reaction mixtures, yet ultra-performance liquid chromatography (UPLC) method selection remains largely experience-driven and difficult to scale. Here, we present a data-driven framework for reaction-level UPLC method recommendation that elevates retention time (RT) prediction from a molecule-level task to an analytical decision problem defined at the level of complete reaction systems. Method-aware RT prediction models were developed for six predefined gradient methods on a shared reversed-phase UPLC platform. For AM-III, SVR achieved an outer-fold mean R2 of 0.941 ± 0.033 under nested cross-validation; within the chemically relevant similarity regime, median relative errors were below 4.46% for AM-I and 3.44% for AM-II. Predicted RTs of the predefined reaction components were aggregated and evaluated using a reaction-level scoring scheme incorporating retention-window constraints, pairwise separation criteria, component-aware weighting, and a veto rule, enabling systematic ranking of candidate methods prior to experimentation. Application to 500 HTE reaction systems spanning SNAr, Chan−Lam, esterification, Buchwald−Hartwig, and amide coupling reactions identified 422 systems (84.4%) as meeting the predicted-RT screening criteria under at least one candidate UPLC method, with recommendations distributed across multiple chromatographic settings rather than collapsing onto a single default condition. Experimental evaluation of 40 HTE reaction systems showed that 35 recommendations (87.5%) satisfied the predefined observed-RT acceptability criterion, supporting the practical utility of the framework within the tested workflow. This work demonstrates how RT prediction can be operationalized as an effective intermediate representation for scalable chromatographic decision-making in high-throughput chemistry.
- 3 November 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
A Data-Driven Framework for UPLC Method Recommendation in High-Throughput Reaction Analysis
High-throughput experimentation (HTE) requires rapid and reliable chromatographic analysis of complex reaction mixtures, yet ultra-performance liquid chromatography (UPLC) method selection remains largely experience-driven and difficult to scale. Here, we present a data-driven framework for reaction-level UPLC method recommendation that elevates retention time (RT) prediction from a molecule-level task to an analytical decision problem defined at the level of complete reaction systems. Method-aware RT prediction models were developed for six predefined gradient methods on a shared reversed-phase UPLC platform. For AM-III, SVR achieved an outer-fold mean R2 of 0.941 ± 0.033 under nested cross-validation; within the chemically relevant similarity regime, median relative errors were below 4.46% for AM-I and 3.44% for AM-II. Predicted RTs of the predefined reaction components were aggregated and evaluated using a reaction-level scoring scheme incorporating retention-window constraints, pairwise separation criteria, component-aware weighting, and a veto rule, enabling systematic ranking of candidate methods prior to experimentation. Application to 500 HTE reaction systems spanning SNAr, Chan−Lam, esterification, Buchwald−Hartwig, and amide coupling reactions identified 422 systems (84.4%) as meeting the predicted-RT screening criteria under at least one candidate UPLC method, with recommendations distributed across multiple chromatographic settings rather than collapsing onto a single default condition. Experimental evaluation of 40 HTE reaction systems showed that 35 recommendations (87.5%) satisfied the predefined observed-RT acceptability criterion, supporting the practical utility of the framework within the tested workflow. This work demonstrates how RT prediction can be operationalized as an effective intermediate representation for scalable chromatographic decision-making in high-throughput chemistry.
Modulating the Optical and Enzymatic Properties of Polydopamine via Valence Engineering of Tungsten Affording NIR‐II Photoacoustic Imaging and Targeted Therapy of Atherosclerosis
Atherosclerosis (AS) is a risk factor for various cardiovascular diseases (CVD), and early diagnosis and plaque removal are challenges in the management of AS and CVD. To address these challenges, we designed a tungsten‑doped polydopamine nanoparticle (W‐PDA NPs). The near‐infrared (NIR) optical absorption and enzymatic properties of W‐PDA were tuned by adjusting the ratio of W 6+ to PDA. It was found that the W‐PDA NPs contain a mixture of W 6+ and W 5+ , which generated large amounts of free electrons, thus conferring both second near‐infrared (NIR‐II) light absorption capability and superoxide dismutase (SOD)‐ and catalase (CAT)‐like activities. Plaque‐targeting was conferred by appending an anti‐osteopontin antibody via coordination between carboxyl moieties of the antibody with W 6+ ions on the W‐PDA surface. The NIR‐II light absorption ability can be utilized for photoacoustic diagnosis of AS, while the SOD‐ and CAT‐like activities facilitate the conversion of superoxide into H 2 O 2 and subsequently O 2 , thereby clearing reactive oxygen species and mitigating inflammation, enabling therapy of AS. Thus, the proposed theranostic agent not only can dynamically report the progression of AS but also can effectively treat AS plaques. This strategy holds broad application prospects in the early and accurate diagnosis and treatment of AS.
Modulating the Optical and Enzymatic Properties of Polydopamine via Valence Engineering of Tungsten Affording NIR‐II Photoacoustic Imaging and Targeted Therapy of Atherosclerosis
Atherosclerosis (AS) is a risk factor for various cardiovascular diseases (CVD), and early diagnosis and plaque removal are challenges in the management of AS and CVD. To address these challenges, we designed a tungsten‑doped polydopamine nanoparticle (W‐PDA NPs). The near‐infrared (NIR) optical absorption and enzymatic properties of W‐PDA were tuned by adjusting the ratio of W 6+ to PDA. It was found that the W‐PDA NPs contain a mixture of W 6+ and W 5+ , which generated large amounts of free electrons, thus conferring both second near‐infrared (NIR‐II) light absorption capability and superoxide dismutase (SOD)‐ and catalase (CAT)‐like activities. Plaque‐targeting was conferred by appending an anti‐osteopontin antibody via coordination between carboxyl moieties of the antibody with W 6+ ions on the W‐PDA surface. The NIR‐II light absorption ability can be utilized for photoacoustic diagnosis of AS, while the SOD‐ and CAT‐like activities facilitate the conversion of superoxide into H 2 O 2 and subsequently O 2 , thereby clearing reactive oxygen species and mitigating inflammation, enabling therapy of AS. Thus, the proposed theranostic agent not only can dynamically report the progression of AS but also can effectively treat AS plaques. This strategy holds broad application prospects in the early and accurate diagnosis and treatment of AS.
- 20 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (30) , 22418-22428
Photoacoustic Probe for Rapidly Recognizing Superoxide Anion Affording Visualized Tracing of Ferroptosis-Mediated Acute Liver Injury
As an emerging form of regulated cell death, ferroptosis has been identified as a key contributor to the pathogenesis of several diseases. Superoxide anion (O2•–), a key reactive oxygen species, is closely associated with ferroptosis-mediated acute liver injury (ALI). The development of in situ, real-time imaging tools capable of visualizing O2•– will benefit the early diagnosis and therapeutic intervention of ferroptosis-mediated ALI. In this work, we designed and synthesized a photoacoustic (PA) probe, Rho-DOH, based on a rhodamine scaffold, for the specific detection of O2•–. Rho-DOH exhibits a highly sensitive, selective, and fast PA response toward O2•–, characterized by a large bathochromic shift of 125 nm and an activation fold of up to 29-fold. Cellular experiments demonstrate that Rho-DOH enables high-contrast PA imaging of endogenous O2•– in cells. Moreover, Rho-DOH was successfully applied to detect the ferroptosis-mediated ALI and to evaluate therapeutic responses through its O2•–-responsive PA imaging signal. These findings position Rho-DOH as a promising molecular imaging tool, offering robust support for the accurate diagnosis and treatment of ferroptosis-associated liver injury.
- 20 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (30) , 22418-22428
Photoacoustic Probe for Rapidly Recognizing Superoxide Anion Affording Visualized Tracing of Ferroptosis-Mediated Acute Liver Injury
As an emerging form of regulated cell death, ferroptosis has been identified as a key contributor to the pathogenesis of several diseases. Superoxide anion (O2•–), a key reactive oxygen species, is closely associated with ferroptosis-mediated acute liver injury (ALI). The development of in situ, real-time imaging tools capable of visualizing O2•– will benefit the early diagnosis and therapeutic intervention of ferroptosis-mediated ALI. In this work, we designed and synthesized a photoacoustic (PA) probe, Rho-DOH, based on a rhodamine scaffold, for the specific detection of O2•–. Rho-DOH exhibits a highly sensitive, selective, and fast PA response toward O2•–, characterized by a large bathochromic shift of 125 nm and an activation fold of up to 29-fold. Cellular experiments demonstrate that Rho-DOH enables high-contrast PA imaging of endogenous O2•– in cells. Moreover, Rho-DOH was successfully applied to detect the ferroptosis-mediated ALI and to evaluate therapeutic responses through its O2•–-responsive PA imaging signal. These findings position Rho-DOH as a promising molecular imaging tool, offering robust support for the accurate diagnosis and treatment of ferroptosis-associated liver injury.
- 30 March 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (14) , 10372-10380
Cell Probe Cocktail Enables Ratiometric miRNA Detection with Enhanced Sensitivity and an Extended Dynamic Range
Sensitive and wide-range detection of miRNA is crucial for monitoring early stage and progressive diseases. However, achieving both high sensitivity and a broad response range in a single sensing platform remains challenging due to the inherent trade-off between these properties. In this study, we develop a novel cell probe cocktail integrated with nicking endonuclease-assisted strand displacement amplification (SDA) for the ratiometric detection of miRNA, enabling concurrent enhancement of sensitivity and expansion of the dynamic range. The counting probes were constructed by conjugating suspended cells with aptamer-functionalized magnetic nanoparticles. A cell probe cocktail system was thus created by combining two types of these counting probes. Leveraging the programmability of DNA, target recognition-induced conformational changes enable the regulation of cell probe assembly and disassembly by modulating the binding of aptamers to cell surface receptors, thereby yielding sensitive, wide-dynamic-range ratiometric readouts. As a proof of concept, ratiometric detection of miRNA-21 over a concentration range of 0.2-100 nM was successfully achieved, with a limit of detection (LOD) of 0.038 nM. The inherent programmability of DNA underscores the versatility of this cell probe cocktail strategy, enabling adaptive sensing across diverse DNA-based architectures.
- 30 March 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (14) , 10372-10380
Cell Probe Cocktail Enables Ratiometric miRNA Detection with Enhanced Sensitivity and an Extended Dynamic Range
Sensitive and wide-range detection of miRNA is crucial for monitoring early stage and progressive diseases. However, achieving both high sensitivity and a broad response range in a single sensing platform remains challenging due to the inherent trade-off between these properties. In this study, we develop a novel cell probe cocktail integrated with nicking endonuclease-assisted strand displacement amplification (SDA) for the ratiometric detection of miRNA, enabling concurrent enhancement of sensitivity and expansion of the dynamic range. The counting probes were constructed by conjugating suspended cells with aptamer-functionalized magnetic nanoparticles. A cell probe cocktail system was thus created by combining two types of these counting probes. Leveraging the programmability of DNA, target recognition-induced conformational changes enable the regulation of cell probe assembly and disassembly by modulating the binding of aptamers to cell surface receptors, thereby yielding sensitive, wide-dynamic-range ratiometric readouts. As a proof of concept, ratiometric detection of miRNA-21 over a concentration range of 0.2-100 nM was successfully achieved, with a limit of detection (LOD) of 0.038 nM. The inherent programmability of DNA underscores the versatility of this cell probe cocktail strategy, enabling adaptive sensing across diverse DNA-based architectures.
- 18 March 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (12) , 9397-9407
Hydroxyl Radical–Activatable NIR-II Ratiometric Fluorescence Probe for Visualization In Vivo Tracking of Oxidative Stress and Therapeutic Response in Arthritis
Oxidative stress plays a pivotal role in the onset and progression of arthritis, in which the abnormal elevation of hydroxyl radical (•OH) has been recognized as a key molecular hallmark of early inflammation. However, effective tools capable of simultaneously visualizing •OH dynamics and tracking therapeutic efficacy remain elusive. Herein, we developed a self-calibrated near-infrared II (NIR-II) ratiometric imaging probe responsive to •OH. The probe integrates downconversion nanoparticles (DCNP) as a stable internal reference (F1550nm,980Ex) and a •OH-triggered red-shiftable dye Hydro-830 (F930nm,808Ex), enabling ratiometric imaging through the signal ratio "F930nm,808Ex/F1550nm,980Ex." The probe exhibits high sensitivity and specificity toward •OH in vitro and effectively captures the upregulation of oxidative stress at early inflammatory stages in vivo. In a longitudinal "treatment-imaging" study, the ratiometric signal gradually decreased following methotrexate (MTX) therapy, consistent with reductions in joint swelling, inflammatory cytokines, and histopathological lesions. This study establishes a self-calibrated NIR-II ratiometric imaging strategy for precise monitoring of oxidative stress, enabling early molecular diagnosis and dynamic therapeutic evaluation of arthritis, and offering a promising paradigm for imaging other ROS-related inflammatory disorders.
- 18 March 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (12) , 9397-9407
Hydroxyl Radical–Activatable NIR-II Ratiometric Fluorescence Probe for Visualization In Vivo Tracking of Oxidative Stress and Therapeutic Response in Arthritis
Oxidative stress plays a pivotal role in the onset and progression of arthritis, in which the abnormal elevation of hydroxyl radical (•OH) has been recognized as a key molecular hallmark of early inflammation. However, effective tools capable of simultaneously visualizing •OH dynamics and tracking therapeutic efficacy remain elusive. Herein, we developed a self-calibrated near-infrared II (NIR-II) ratiometric imaging probe responsive to •OH. The probe integrates downconversion nanoparticles (DCNP) as a stable internal reference (F1550nm,980Ex) and a •OH-triggered red-shiftable dye Hydro-830 (F930nm,808Ex), enabling ratiometric imaging through the signal ratio "F930nm,808Ex/F1550nm,980Ex." The probe exhibits high sensitivity and specificity toward •OH in vitro and effectively captures the upregulation of oxidative stress at early inflammatory stages in vivo. In a longitudinal "treatment-imaging" study, the ratiometric signal gradually decreased following methotrexate (MTX) therapy, consistent with reductions in joint swelling, inflammatory cytokines, and histopathological lesions. This study establishes a self-calibrated NIR-II ratiometric imaging strategy for precise monitoring of oxidative stress, enabling early molecular diagnosis and dynamic therapeutic evaluation of arthritis, and offering a promising paradigm for imaging other ROS-related inflammatory disorders.
- 12 March 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (11) , 8487-8499
Integrated Enzyme-Powered DNA-Gold Nanomachine for In Vivo Amplified mRNA Photoacoustic Imaging and Enhanced Tumor Photothermal Therapy
Developing activatable nanotheranostics that can improve diagnostic and therapeutic performances and reduce side effects is highly attractive for precision cancer medicine but remains a daunting challenge. Herein, we develop an integrated enzyme-powered DNA-gold nanomachine (DGNM@CM) for the simultaneous amplification of in vivo mRNA photoacoustic (PA) imaging and tumor-specific photothermal therapy (PTT). The DGNM@CM consists of a gold nanoparticle (AuNP) core, an interlayer of linker DNA and partially complementary DNA duplex, which is bound to aptamer-inhibited DNA polymerase, and an outer layer of the tumor cell membrane (CM). Once specifically internalized by target tumor cells, the tumor-related mRNA target interacts with DGNM@CM, initiating a strand-displacement reaction and releasing an active DNA polymerase. This reaction induces the aggregation of AuNPs, which shift their absorption from the visible to near-infrared region, thereby simultaneously activating PA imaging and PTT. More importantly, the released active DNA polymerase can catalyze the recycling of target mRNA through cyclic strand-displacement polymerization reaction and induce the continuous aggregation of AuNPs, thus realizing significant amplification of both PA imaging signals and PTT efficacy. This DGNM@CM can accurately diagnose tumors in vivo and impressively suppress tumor growth with negligible toxicity. The developed DGNM@CM can be extended for the amplified PA detection of other biomolecules and the activation of therapy by them by changing corresponding DNA sequences, thus possessing broad application prospects in biosensing, bioimaging, and precision disease theranostics.
- 12 March 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (11) , 8487-8499
Integrated Enzyme-Powered DNA-Gold Nanomachine for In Vivo Amplified mRNA Photoacoustic Imaging and Enhanced Tumor Photothermal Therapy
Developing activatable nanotheranostics that can improve diagnostic and therapeutic performances and reduce side effects is highly attractive for precision cancer medicine but remains a daunting challenge. Herein, we develop an integrated enzyme-powered DNA-gold nanomachine (DGNM@CM) for the simultaneous amplification of in vivo mRNA photoacoustic (PA) imaging and tumor-specific photothermal therapy (PTT). The DGNM@CM consists of a gold nanoparticle (AuNP) core, an interlayer of linker DNA and partially complementary DNA duplex, which is bound to aptamer-inhibited DNA polymerase, and an outer layer of the tumor cell membrane (CM). Once specifically internalized by target tumor cells, the tumor-related mRNA target interacts with DGNM@CM, initiating a strand-displacement reaction and releasing an active DNA polymerase. This reaction induces the aggregation of AuNPs, which shift their absorption from the visible to near-infrared region, thereby simultaneously activating PA imaging and PTT. More importantly, the released active DNA polymerase can catalyze the recycling of target mRNA through cyclic strand-displacement polymerization reaction and induce the continuous aggregation of AuNPs, thus realizing significant amplification of both PA imaging signals and PTT efficacy. This DGNM@CM can accurately diagnose tumors in vivo and impressively suppress tumor growth with negligible toxicity. The developed DGNM@CM can be extended for the amplified PA detection of other biomolecules and the activation of therapy by them by changing corresponding DNA sequences, thus possessing broad application prospects in biosensing, bioimaging, and precision disease theranostics.
- 10 December 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (10)
Construction of tri-input DNA circuits via a double-blocking strategy for spatiotemporally precise in vivo fluorescence imaging
- 10 December 2025
- Published by Elsevier in Chinese Chemical Letters
- Vol. 37 (10)
Construction of tri-input DNA circuits via a double-blocking strategy for spatiotemporally precise in vivo fluorescence imaging
- Open Access
- 3 November 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (1) , 299-309
In Vivo Evaluation of Liver Injury and Arthritis Enabled by a Nitroxyl-Activated Near-Infrared Fluorescence and Photoacoustic Dual-Modality Imaging Probe
Nitroxyl (HNO) is the transient form of nitric oxide (NO) and is highly reactive, which makes its in vivo study a significant challenge. We report here simultaneous fluorescence and photoacoustic imaging of HNO, enabled by a newly synthesized near-infrared, dual-modality fluorescence and photoacoustic (FPA) probe. The 2-(diphenylphosphonyl)benzoate moiety in the FPA probe specifically recognized HNO. The photophysical properties of the probe were tuned, e.g., by substituting an oxygen atom in the hemicyanine moiety with sulfur, resulting in a 45 nm red-shift. The maximum absorption wavelength increased from 650 nm in the absence of HNO to 760 nm in the presence of HNO. We demonstrate an application of the HNO-activated FPA probe to in vivo evaluation of inflammatory disease progression in a mouse model. Treatment of mice with acetaminophen stimulated endogenous generation of HNO in their liver, which was successfully imaged using dual-modality near-infrared fluorescence and photoacoustic measurements. Fluorescence and photoacoustic imaging of the ankle site of an arthritis mouse model enabled a study of the onset of this inflammatory disease.
- 3 November 2025
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (1) , 299-309
Open AccessIn Vivo Evaluation of Liver Injury and Arthritis Enabled by a Nitroxyl-Activated Near-Infrared Fluorescence and Photoacoustic Dual-Modality Imaging Probe
Nitroxyl (HNO) is the transient form of nitric oxide (NO) and is highly reactive, which makes its in vivo study a significant challenge. We report here simultaneous fluorescence and photoacoustic imaging of HNO, enabled by a newly synthesized near-infrared, dual-modality fluorescence and photoacoustic (FPA) probe. The 2-(diphenylphosphonyl)benzoate moiety in the FPA probe specifically recognized HNO. The photophysical properties of the probe were tuned, e.g., by substituting an oxygen atom in the hemicyanine moiety with sulfur, resulting in a 45 nm red-shift. The maximum absorption wavelength increased from 650 nm in the absence of HNO to 760 nm in the presence of HNO. We demonstrate an application of the HNO-activated FPA probe to in vivo evaluation of inflammatory disease progression in a mouse model. Treatment of mice with acetaminophen stimulated endogenous generation of HNO in their liver, which was successfully imaged using dual-modality near-infrared fluorescence and photoacoustic measurements. Fluorescence and photoacoustic imaging of the ankle site of an arthritis mouse model enabled a study of the onset of this inflammatory disease.
- 12 March 2025
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 36 (4) , 803-814
Exceptional Near-Infrared II Organic Small Molecule Nanoagent for Photoacoustic/Photothermal Imaging-Guided Highly Efficient Therapy in Cancer
Near-infrared II (NIR-II) photoacoustic (PA)/photothermal imaging-guided tumor therapy holds great promise in precision medicine for cancer treatment. This work reports on the synthesis and application of an organic small molecule nanoagent that has exceptional PA and photothermal properties in the near-infrared region. BCy-TPE was constructed by linking an NIR-II absorbing cyanine dye BCy-Cl with a twisted tetraphenylethene unit. The synthesized BCy-TPE exhibited an intense absorption peak at 1032 nm. After encapsulation into water-dispersible nanoparticles (NPs), BCy-TPE NPs exhibited two absorption peaks at 880 and 1046 nm. Notably, under 1064 nm laser excitation, BCy-TPE NPs deliver a remarkable photothermal conversion efficiency of 92%, together with superior biocompatibility, photostability, and PA/photothermal imaging capability. Moreover, after intravenous administration of BCy-TPE NPs into 4T1 tumor-bearing mice and treatment with safe-intensity (1.0 W cm-2 and 1064 nm) laser irradiation, tumor temperature increased rapidly to 52 °C within 1 min and tumors are completely ablated after a single photothermal therapy treatment. Overall, this work offers a novel strategy to develop superb NIR-II photothermal agents for PA/photothermal imaging-guided highly efficient therapy in cancer.
- 12 March 2025
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 36 (4) , 803-814
Exceptional Near-Infrared II Organic Small Molecule Nanoagent for Photoacoustic/Photothermal Imaging-Guided Highly Efficient Therapy in Cancer
Near-infrared II (NIR-II) photoacoustic (PA)/photothermal imaging-guided tumor therapy holds great promise in precision medicine for cancer treatment. This work reports on the synthesis and application of an organic small molecule nanoagent that has exceptional PA and photothermal properties in the near-infrared region. BCy-TPE was constructed by linking an NIR-II absorbing cyanine dye BCy-Cl with a twisted tetraphenylethene unit. The synthesized BCy-TPE exhibited an intense absorption peak at 1032 nm. After encapsulation into water-dispersible nanoparticles (NPs), BCy-TPE NPs exhibited two absorption peaks at 880 and 1046 nm. Notably, under 1064 nm laser excitation, BCy-TPE NPs deliver a remarkable photothermal conversion efficiency of 92%, together with superior biocompatibility, photostability, and PA/photothermal imaging capability. Moreover, after intravenous administration of BCy-TPE NPs into 4T1 tumor-bearing mice and treatment with safe-intensity (1.0 W cm-2 and 1064 nm) laser irradiation, tumor temperature increased rapidly to 52 °C within 1 min and tumors are completely ablated after a single photothermal therapy treatment. Overall, this work offers a novel strategy to develop superb NIR-II photothermal agents for PA/photothermal imaging-guided highly efficient therapy in cancer.